529P Evaluating Metastatic Disease Sites As a Prognostic Marker in Patients Receiving Sequential Treatment with Regorafenib and Trifluridine/tipiracil for Refractory Colorectal Cancer: Survival Outcomes from the Multicenter Retrospective “retrita” Study
Annals of Oncology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要